Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Liminatus Pharma, Inc. publishes a filing, an earnings call transcript or a press release.

Get LIMN alerts

About Chris Kim

Chris Kim is recorded as Board Member and CEO at Liminatus Pharma, Inc. (LIMN). The newest filing on record that lists Chris Kim as Board Member and CEO at Liminatus Pharma, Inc. (LIMN) is dated July 13, 2026. Liminatus Pharma, Inc. reported in an 8-K filed May 6, 2025 that Chris Kim was appointed Chief Executive Officer. Liminatus Pharma, Inc. reported in an 8-K filed May 6, 2025 that Chris Kim was appointed Company’s Board of Directors. Liminatus Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Liminatus Pharma, Inc. includes Scott Dam (CFO), Beom K. Choi (CTO), Eun Sook Lee (Board Member) and 4 others.

“Further, upon the consummation of the Business Combination, (i) Sumit Mehta resigned from his position as Chief Executive Officer, Lisha Parmar resigned from her position as Chief Financial Officer and Omkar Halady resigned from his position as Vice President, and (ii) Chris Kim was appointed as Chief Executive Officer, Scott Dam was appointed as Chief Financial Officer, Byong C. Yoo was appointed as Chief Science Officer, Sang-jin Daniel Lee was appointed as Head of Research and Development, and Beom K. Choi was appointed as Chief Technology Officer.”
Liminatus Pharma, Inc. Form 8-K, filed May 6, 2025 · Read the filing
“Upon the consummation of the Business Combination, (i) the following Iris’s board members resigned in connection with the Business Combination: Rohit Nanani, Richard Peretz, Manish Shah and Nicholas Fernandez; and (ii) Chris Kim, Eun Sook Lee, Nicholas Fernandez and Ji Yeon Baek were appointed to the Company’s Board of Directors.”
Liminatus Pharma, Inc. Form 8-K, filed May 6, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Liminatus Pharma, Inc.

Recent activity